A panel of U.S. health advisers endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.

Join The Ecosystem

Leave a Reply

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}